QC to end deal with eZConsult firm due to frequent glitches, eyes filing charges | Inquirer News

QC to end deal with eZConsult firm due to frequent glitches, eyes filing charges

By: - Reporter / @DYGalvezINQ
/ 12:53 AM June 30, 2021

Joy Belmonte on COVID vaccines

Quezon City Mayor Joy Belmonte. (File photo by NIÑO JESUS ORBETA / Philippine Daily Inquirer)

MANILA, Philippines — The Quezon City government has decided to terminate its contract with Zuellig Pharma Corp., the firm behind the eZConsult virtual care network after users experienced frequent glitches in booking a COVID-19 vaccination slot.

The last straw was on Tuesday afternoon when the system crashed for the ninth time, making users wait for hours to book a slot.

Article continues after this advertisement

“We have already given Zuellig ample time to improve their system upon their request and yet their system has crashed again for the ninth time. We don’t want to cause undue stress to our constituents who only want to register for vaccination,” Mayor Joy Belmonte said in a statement issued on Tuesday.

FEATURED STORIES

The city government recently issued an ultimatum to Zuellig for them to improve their system.

Belmonte said the firm had reported an upgrade of their system, which supposedly could accommodate up to 50,000 users at a time, but the system crashed again when the government opened new slots.

Article continues after this advertisement

“Instead of speeding up, the registration process became slower. What’s sad is that it’s the people who are suffering, and it wasted the efforts of our medical frontliners and volunteers, who have been sacrificing to for several months to speed up the vaccination process,” Bellmonete said in Filipino.

Article continues after this advertisement

Belmonte said the city government would file civil and criminal charges against the firm.

Article continues after this advertisement

“We are filing appropriate charges against them through our Legal Department. We are doing this for the interest of our QCitizens and to protect their rights,”  she said.

According to city attorney Orlando Casimiro,  Zuellig breached its contractual obligations to the city for failing to deliver on its commitment to improve its service.

Article continues after this advertisement

“The Information Technology portion of the Service Agreement with the city government will be terminated and damages will be claimed against Zuellig because of the delays, inconvenience, and frustration that our QCitizens have experienced,” Casimiro said in a statement.

Under the agreement, Zuellig is liable to pay liquidated damages amounting to one-tenth of one percent of the contract price for every day of delay until the project is completed, according to the city government.

It added that EzConsult reported several technical difficulties beginning March 27 this year that delayed the vaccination of city residents.

Belmonte urged residents experiencing difficulties registering on the EzConsult website to instead register at the city government-assisted QC Vax Easy portal.

Those who were able to book a slot for July 1 to 3 and July 5 to 6 are advised to proceed to the vaccination site of their choice as scheduled.

Until the contract termination has been finalized, all ongoing bookings are valid, the city statement said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Those scheduled for the second dose should also follow the date indicated in their card and have their vaccination at the same site where they had their first dose.

[atm]
TAGS: eZConsult, Quezon City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.